基本信息
浏览量:13
职业迁徙
个人简介
Charles L. Loprinzi, M.D., is a medical oncologist whose primary research interest for more than 25 years has related to symptom control clinical trials — trials devoted to the treatment, prevention or better understanding of untoward symptoms that are related to cancer, cancer treatment or both.
Dr. Loprinzi has led a group that has conducted well over 100 symptom control trials, most of them placebo-controlled trials. This work has addressed the management of mouth sores or inflammation of the esophagus or bowels (gastrointestinal mucosal toxicity); cancer-related loss of appetite, weight or both (anorexia-cachexia); chemotherapy-induced hot flashes, skin toxicity, sexuality symptoms, numbness, tingling, pain or a combination (chemotherapy-induced neuropathy); arm swelling (lymphedema); cognitive dysfunction; bone thinning (osteoporosis); insomnia; and fatigue. His primary clinical interest is breast cancer, and thus many of the trials he has conducted relate to this area.
Arguably, Dr. Loprinzi has been at the heart of defining more treatment approaches for uncontrolled symptoms in patients with cancer than any other individual over the past three decades.
Focus areas
Chemotherapy-induced peripheral neuropathy. Dr. Loprinzi and his team have led more clinical trials aimed at the prevention or treatment of chemotherapy-induced neuropathy than any other group in the world. Through these efforts, he has been able to delineate the risks and benefits of different treatment approaches for preventing or treating chemotherapy neuropathy. His work has also helped to define the clinical details of chemotherapy neuropathy.
Hot flashes. Hot flashes are a major problem for many women and men who have therapy to deplete testosterone. Dr. Loprinzi's research group has conducted more trials aimed at the treatment of hot flashes in women and men than any other group in the world. He and his group have been able to delineate nonestrogenic treatments that are effective for hot flashes. This includes the use of low doses of antidepressants for treating hot flashes.
Anorexia and cachexia. Appetite loss and weight loss are common in many patients with advanced cancer. Dr. Loprinzi and his group have conducted more clinical trials aimed at treatment of these vexing problems than any other group in the world. Through this work, they have been able to define what works and what does not work for treatment of this clinical situation.
研究兴趣
论文共 782 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical breast cancerno. 1 (2024): 72-78.e4
B.J. Stish, Gina L. Mazza,Jones T. Nauseef, Michael S. Humeniuk,Thomas J. Smith, Cindy Tofthagen, D.A. Diaz Pardo, Christopher H. Chay, Andrew Huang, Kushal Naha,Scott T. Tagawa,Selina Chow, Lucile L. Adams‐Campbell,Paul J. Novotny,Charles L. Loprinzi
Journal of clinical oncologyno. 17_suppl (2024): LBA12004-LBA12004
Vered Stearns,Opeyemi A. Jegede, Victor T.-S. Chang,Todd C. Skaar,Jeffrey L. Berenberg, Ranveer Nand,Atif Shafqat,Nisha L. Jacobs,William Luginbuhl,Paul Gilman,Al B. Benson, Judie R. Goodman,Gary L. Buchschacher,N. Lynn Henry,Charles L. Loprinzi,Patrick J. Flynn,Edith P. Mitchell,Michael J. Fisch,Joseph A. Sparano,Lynne I. Wagner
crossref(2024)
Cancer Researchno. 9_Supplement (2024): PO2-13
JNCI CANCER SPECTRUMno. 1 (2024)
Robert D. McBane,Charles L. Loprinzi,Tyler Zemla,Alfonso Tafur,Kristen M. Sanfilippo, Jane Jijun Liu,David García, James M. Heun,Krishna Gundabolu,Adedayo A. Onitilo,Usha Perepu,Monic R. Drescher,Stanislav Henkin, Damon E. Houghton,Aneel A. Ashrani,Henny H. Billett,Shaylene McCue,Minji K. Lee,Jennifer Le‐Rademacher,Waldemar E. Wysokiński
Journal of thrombosis and haemostasis (2024)
Journal of Clinical Oncologyno. 16_suppl (2024): 12048-12048
Cancer Researchno. 9_Supplement (2024): PO5-12
Cancer Treatment Reviews (2024): 102748-102748
Scientific reportsno. 1 (2024)
加载更多
作者统计
#Papers: 782
#Citation: 43403
H-Index: 104
G-Index: 189
Sociability: 8
Diversity: 0
Activity: 4
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn